Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions

Transcriptomics secondary analysis of severe human infection with SARS-CoV-2 identifies gene expression changes and predicts three transcriptional biomarkers in leukocytes

“…These results present a potential blood-based diagnostic for severe infections with SARS-CoV-2. Considering the diversity of reactions that patients have to the virus, incorporating these biomarkers as additional data points to assess patient risk of severe disease could be pivotal in augmenting the clinical decision making processes [107] , [108] , [109] . This is especially relevant when resources may be limited and priority must be given to those with severe infection.…”

Transcriptomics Meta-Analysis Predicts Two Robust Human Biomarkers for Severe Infection with SARS-CoV-2

“…These results present a potential predictor for the severity levels of patients infected with SARS-CoV-2. Considering the diversity of reactions that patients have to the virus, incorporating these biomarkers as additional data points to assess patient risk of severe disease could be pivotal in augmenting both personal and public health decision making processes [64][65][66]. This is especially relevant when resources may be limited and priority must be given to those with the greatest risk of severe infection.…”

Update of European Society of Clinical Microbiology and Infectious Diseases coronavirus disease 2019 guidelines: diagnostic testing for severe acute respiratory syndrome coronavirus 2

“… In asymptomatic patients ≥12 years old without risk factors for severe COVID-19, we suggest the use of laboratory-based NAAT versus rapid antigen testing for the diagnosis of COVID-19. Weak against Low [ 11 , 20 , 49 , 54 , 55 , 65 , 70 , 71 , 77 , 83 , 89 , 94 , 22 , 111 , 113 , 121 , 128 , 130 , 137 , [143] , [144] , [145] , [146] , 24 , [147] , [148] , [149] , 158 , [160] , [161] , [162] , [163] , [164] , [165] , 28 , [166] , [167] , [168] , [169] , [170] , [171] , [172] , [173] , [174] , [175] , 34 , 176 , 40 , 43 , 44 , 46 ] 3 In asymptomatic people of any age with any risk factor(s) for severe COVID-19 (including age <3 or ≥65 years) should rapid antigen tests be used, as compared to laboratory-based ...…”

“… In asymptomatic people, we suggest the use of laboratory-based NAAT in nasopharyngeal samples versus rapid antigen testing in nasopharyngeal samples for the diagnosis of COVID-19. Weak against Low [ 11 , 18 , 38 , 43 , 44 , 46 , 47 , 49 , 50 , [54] , [55] , [56] , 20 , 57 , 65 , 67 , 68 , 70 , 71 , 77 , 81 , 83 , 86 , 22 , 87 , 90 , 92 , 94 , 99 , 102 , 113 , 155 , 158 , 160 , 24 , [161] , [162] , [163] , 165 , 168 , 170 , [172] , [173] , [174] , [175] , 28 , [176] , [177] , [178] , [179] , [180] , [181] , [182] , [183] , [29] , [30] ...…”

“…[ 27 ]; [ 30 ]; [ 32 ]; [ 42 ]; [ 51 ]; [ 52 ]; [ 58 ]; [ 59 ]; [ 69 ]; [ 72 ]; [ 74 ]; [ 80 ]; [ 84 ]; [ 88 ]; [ 98 ]; [ 103 ]; [ 134 ]; [ 144 ]; [ 145 ]; [ 150 ]; [ 153 ]; [ 157 ]; [ 162 ]; [ 169 ]; [ 173 ]; [ 174 ]; [ 178 ]; [ 179 ]; [ 180 ]; [ 181 ]; [ 182 ].…”